Target intelligence / Profile preview

CENATAC pseudogene 1 (CENATACP1)

Target
CENATACP1
Molecular classification
Other (pseudogene)
01

Overview

CENATAC pseudogene 1 (CENATACP1) is a genomic locus classified as a pseudogene, related to the protein-coding gene CENATAC (Centrosomal AT-AC Splicing Factor). Unlike the functional CENATAC gene, CENATACP1 does not encode a functional protein and is considered a defunct genetic copy resulting from gene duplication or retrotransposition events. Pseudogenes typically lack biological activity and do not participate in cellular functions such as signal transduction, cell cycle regulation, or disease pathology. Current knowledge does not implicate CENATACP1 in human diseases, drug interactions, or therapeutic targeting.[1][7][9][11] CENATACP1 is a pseudogene, not a protein-coding gene, receptor, enzyme, or transporter; therefore, it is not considered a therapeutic target[1][7][9][11]. There is no evidence of biological function, clinical relevance, or disease association for this pseudogene itself. Sometimes, pseudogenes have regulatory or non-coding RNA roles, but no such role is described for CENATACP1 in current sources[8][11]. The parent gene, CENATAC, is a component of the minor spliceosome, with roles in chromosome segregation and associated with rare congenital disorders when mutated, but these facts do not extend to the pseudogene[2][4]. CENATAC pseudogene 1 (CENATACP1) is a pseudogene; it is not a therapeutic target, lacks function and disease associations, and is not used as a biomarker. Its parent gene, CENATAC, is functionally relevant, but this does not apply to the pseudogene[1][2][4][7][11].

Other names
CENATACP1
02

Mechanism of action

null

Beyond the preview

Go deeper on CENATAC pseudogene 1 (CENATACP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CENATAC pseudogene 1 (CENATACP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call